Latest News

In the past week, O'Reilly Automotive drew attention as it approached its first-quarter earnings release, with analysts forecasting a double-digit adjusted EPS increase and management guiding for comparable store sales growth of 3% to 5% alongside an EPS outlook for 2026 between $3.10 and $3.20. Despite a recent period of weaker share performance and softer quarterly results, O'Reilly continues to post average same-store sales growth of 3.8% per year over the last two years while sustaining...

On March 26, 2026, ADW Capital Management issued an open letter to Driven Brands Holdings’ board urging an immediate strategic review, criticizing governance, capital allocation, and the costly car wash expansion and exit, while calling for independent advisors, overhead cuts, and greater transparency. ADW Capital argues these issues have created a major gap between Driven Brands’ business value and its market valuation, suggesting that a controlled sale or breakup could unlock materially...

Why United Airlines Holdings Stock Is On Investors’ Radar Without a clear single news catalyst, United Airlines Holdings (UAL) is drawing attention after a run of mixed returns, with gains over the past year but weaker performance in the month and past 3 months. See our latest analysis for United Airlines Holdings. At a share price of $88.44, United Airlines Holdings has seen a 30 day share price return of 16.8% and a year to date share price return of 21.74% decline, while its 1 year total...

What Recent Performance Says About First Industrial Realty Trust First Industrial Realty Trust (FR) has drawn attention after a recent 1-day decline, along with a 1-month return of about 9% lower and a mild negative move over the past 3 months. For investors watching industrial real estate, the stock's 1-year total return of 10.25% sits next to a value score of 2 and an indicated intrinsic discount of about 15%. Together, these figures may provide an interesting starting point for further...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Delivery Hero (XTRA:DHER) has investors’ attention after reporting full year 2025 earnings, with sales of €14,059.6 million, a reduced net loss of €782.9 million and a narrower basic loss per share. See our latest analysis for Delivery Hero. The earnings release, refinancing update and quick commerce expansion plans have come against a weak backdrop for the stock, with a 1-year total shareholder return decline of 26.40% and a 5-year total shareholder return decline of 85.52%. The 7-day share...

AeroVironment (AVAV) has put its LOCUST X3 high energy laser system at the center of the story, highlighting AI-enabled drone defense and modular design as a fresh reference point for the stock. See our latest analysis for AeroVironment. Despite the high profile LOCUST X3 launch and recent media attention, AeroVironment’s 30 day share price return of 26.89% and year to date share price return of 28.01% are negative, while its 1 year total shareholder return of 52.51% and 3 year total...

Why United Natural Foods is Back on Investors’ Radar United Natural Foods (UNFI) has attracted fresh attention after recent share price moves, with the stock showing strong gains over the past month and past 3 months. This has prompted investors to reassess the distributor’s current valuation and risk profile. See our latest analysis for United Natural Foods. Those short term gains sit on top of a much stronger longer term picture, with a 37.4% year to date share price return and a 72.0%...

RH (RH) has drawn fresh attention after appointing long-time manufacturing partner executive Veronica Schnitzius to lead manufacturing and sourcing, alongside the return of real estate veteran David Stanchak to oversee expansion and asset monetization. See our latest analysis for RH. Those leadership changes arrive after a sharp reset in investor expectations, with the 30 day share price return of RH at a 21.04% decline and the 1 year total shareholder return down 44.62%. This points to...

Green Plains (GPRE) has drawn fresh attention as investors reassess its role in low carbon fuels, with recent returns over the month and past 3 months prompting closer scrutiny of its fundamentals. See our latest analysis for Green Plains. At a share price of $16.89, Green Plains has seen a 30 day share price return of 23.02% and a 90 day share price return of 71.47%. Its 1 year total shareholder return of 247.53% contrasts with weaker 3 and 5 year total shareholder returns, suggesting strong...

Marex Group plc recently issued earnings guidance for the first quarter ended March 31, 2026, forecasting revenues between US$667 million and US$697 million, compared with US$467 million in the same period of 2025. This guidance implies a sharp year-on-year uplift in expected quarterly revenue, hinting at materially stronger client activity and business momentum across Marex’s platform. We’ll now examine how this significantly higher first-quarter 2026 revenue outlook influences Marex...

In March 2026, Tarsus Pharmaceuticals announced that its partner Grand Pharmaceutical Group secured National Medical Products Administration approval in China for TP-03 (XDEMVY) to treat Demodex blepharitis, triggering a US$15,000,000 milestone payment to Tarsus and confirming TP-03 as the first approved therapy addressing the disease’s root cause in Greater China. This approval not only validates TP-03’s clinical and regulatory profile outside the U.S., but also opens a new revenue stream...

Why BlackBerry stock is on investors’ radar BlackBerry (TSX:BB) continues to attract attention after a period of weaker share performance, with the stock showing negative returns over the past year and past 3 months, even as its core software business remains focused on security and automotive technology. See our latest analysis for BlackBerry. At a share price of CA$4.38, BlackBerry has logged a 17.5% 3 month share price decline and a 59.3% 5 year total shareholder return loss, pointing to...

Monte Rosa Therapeutics, Inc. recently reported a fourth-quarter 2025 net loss of US$46.14 million and entered a supply agreement with Johnson & Johnson to evaluate its investigational molecular glue degrader MRT-2359 in combination with ERLEADA in a planned Phase 2 study for metastatic castration-resistant prostate cancer. This collaboration, together with positive early data for MRT-2359 presented at the 2026 ASCO GU Cancers Symposium, highlights growing external interest in Monte Rosa’s...

Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) just received Chinese regulator approval for its SKB103 IND in advanced solid tumors, marking a new clinical milestone that comes alongside recent earnings and oncology trial updates. See our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical. The regulatory green light for SKB103 comes after a series of oncology updates and full-year 2025 results. The share price has reacted, with a 7.07% 1-day share price return and 18.12% 30-day...

Earlier this month, UFP Packaging, a division of UFP Industries, introduced Slot-Lock and Clamp-Lock 100 industrial crate systems that enable nail-gun-free, pneumatic-free assembly, emphasizing safer construction, reusability, and reduced waste across sectors from aerospace to infrastructure. This product launch highlights UFP’s push into higher-value engineered packaging solutions that aim to improve customer safety and efficiency while expanding its differentiated, customizable...

Recent share performance and current context Pernod Ricard (ENXTPA:RI) has seen its share price move unevenly, with a roughly flat 7 day return, a double digit decline over the past month, and a smaller negative move across the past 3 months. See our latest analysis for Pernod Ricard. The recent 7.9% 1 day share price return to €64.7 comes after a 17.3% 30 day share price decline and sits against a 27.4% 1 year total shareholder return loss, suggesting momentum has been fading over a longer...

In March 2026, T&D Holdings, Inc. raised its fiscal 2026 ordinary revenue forecast to ¥3.42 trillion and lifted expected earnings per share to ¥237.45, citing stronger-than-anticipated insurance premium income from higher sales of single premium products, while leaving profit guidance unchanged. The company also increased its year-end dividend guidance to ¥68 per share and introduced a new policy targeting cash dividends of about 60% of five-year average Group adjusted profit, signaling a...

Celcuity (CELC) has been in focus after the FDA accepted its New Drug Application for gedatolisib with priority review, while management simultaneously accelerates commercial preparation ahead of a potential launch. See our latest analysis for Celcuity. The share price has been volatile around these updates, with a 1 day share price return of negative 7.66% and a 30 day share price return of negative 5.09%. However, the 1 year total shareholder return is very large and indicates that longer...

Adecoagro S.A. recently filed a US$21.50 million shelf registration for 1,727,040 common shares tied to an ESOP, following fourth-quarter 2025 results showing sales of US$415.94 million and a net loss of US$14.85 million. The combination of higher quarterly sales but a swing to loss, alongside potential equity issuance for employee ownership, raises fresh questions about how Adecoagro is balancing growth, profitability, and capital structure. We’ll now examine how the ESOP-linked shelf...

Globus Medical, Inc. recently announced that Director John A. DeFord, PhD, resigned from its Board of Directors with immediate effect and will not stand for re-election at the June 3, 2026 Annual Meeting, leaving his role on the Nominating and Governance Committee. At the same time, new analyst coverage from Wells Fargo has drawn attention to Globus Medical’s execution, product portfolio expansion and updated 2026 outlook, sharpening focus on how governance and growth plans align. Against...

Diversified Energy recently announced a new share buyback program running through March 2027, targeting the repurchase of about 7.8 million shares and disclosing a completed buyback of 300,000 shares, while President and CFO Bradley Gray gifted 15,000 shares to family members, reducing his beneficial ownership to 212,790 shares. This combination of an expanded capital return plan and updated insider holdings offers fresh insight into how management is currently aligning with...

Wynn Macau (SEHK:1128) has drawn fresh attention after releasing full year 2025 results that show revenue broadly steady while net income declined, alongside a higher recommended final ordinary dividend. See our latest analysis for Wynn Macau. The full year results and higher proposed dividend come after a mixed share price run, with a 7 day share price return of 4.50%, a 90 day share price return of 6.86% and a year to date share price return of 7.17%, while the 1 year total shareholder...